Gyno-Canesten Monodose (Clotrimazole)

Gyno-Canesten Monodose is indicated for the topical treatment of uncomplicated vaginal candidiasis caused by susceptible Candida species.

• Provides rapid relief of itching, burning, and abnormal vaginal discharge associated with yeast infection.
• Eradicates Candida overgrowth on the vaginal mucosa, helping restore normal flora.
• Can be used for a single‑dose regimen in women with mild to moderate symptoms.
• May be recommended for recurrent episodes when combined with preventive hygiene measures.
• Suitable for adult women who have been diagnosed with uncomplicated vaginal candidiasis.

Side effects of Gyno-Canesten Monodose are generally mild and reversible, but rare serious reactions may occur.

Common

• Mild vaginal irritation or burning.
• Itching or redness of the vulvar area.
• Discomfort during application.
• Transient increase in vaginal discharge.
• Temporary spotting or light bleeding after insertion.

Serious

• Severe allergic reaction such as swelling of the face, lips, or tongue.
• Rapid onset of hives or rash.
• Signs of systemic infection (fever, chills) although uncommon.

Before using Gyno-Canesten Monodose, consider the following precautions to ensure safe and effective treatment.

• Confirm the diagnosis of vaginal candidiasis; avoid use for bacterial vaginosis or other infections.
• Do not use if you are allergic to clotrimazole or any other azole antifungals.
• Pregnancy and lactation status should be discussed with a healthcare provider, as safety data are limited.
• If symptoms persist beyond the recommended treatment period, seek medical evaluation.
• Avoid inserting other vaginal products (e.g., douches, spermicides) during treatment.
• Store the product at room temperature, away from moisture and direct heat.

Clotrimazole may interact with certain medications or substances; awareness of these interactions helps prevent reduced efficacy or adverse effects.

Avoid

• Concurrent use of systemic azole antifungals (e.g., fluconazole) that may increase systemic exposure.
• Topical products containing other antifungal agents, which could cause irritation.
• Concurrent use of topical estrogen preparations may alter vaginal pH and affect drug performance.

Use with caution

• Hormonal contraceptives, as vaginal irritation could affect absorption.
• Antibiotics that alter vaginal flora, potentially affecting treatment outcome.
• Chemotherapeutic agents that suppress immunity, increasing risk of fungal infection.
• Patients using systemic corticosteroids should monitor for signs of fungal overgrowth.